Page 1
Trial Overview
Trial Phase
Trial Purpose
Trial Duration
Number of Participants
Participant Population
Investigational Product
Product Type
Mechanism of Action
Formulation
Route of Administration
Prior Clinical Experience
Regulatory Considerations
Regulatory Approvals Obtained
Potential Regulatory Risks
Clinical Site Information
Number of Clinical Sites
Site Experience with Investigational Product
Site Infrastructure Capabilities
Site Monitoring Plan
Patient Population Risks
Participant Recruitment Feasibility
Participant Retention Risks
Participant Inclusivity
Participant Vulnerability
Safety Considerations
Anticipated Adverse Events
Potential Safety Signals
Mitigation Strategies
Overall Risk Assessment
Risk Level
Justification
Mitigation Plan